Immunoprecise Antibodies Ltd
XTSX:IPA
Income Statement
Earnings Waterfall
Immunoprecise Antibodies Ltd
Revenue
|
19m
CAD
|
Cost of Revenue
|
-8.6m
CAD
|
Gross Profit
|
10.5m
CAD
|
Operating Expenses
|
-25.5m
CAD
|
Operating Income
|
-15m
CAD
|
Other Expenses
|
-2.1m
CAD
|
Net Income
|
-17.1m
CAD
|
Income Statement
Immunoprecise Antibodies Ltd
Jan-2022 | ||
---|---|---|
Revenue | ||
Revenue |
19
N/A
|
|
Gross Profit | ||
Cost of Revenue |
(9)
|
|
Gross Profit |
10
N/A
|
|
Operating Income | ||
Operating Expenses |
(25)
|
|
Selling, General & Administrative |
(17)
|
|
Research & Development |
(6)
|
|
Depreciation & Amortization |
(3)
|
|
Operating Income |
(15)
N/A
|
|
Pre-Tax Income | ||
Interest Income Expense |
(1)
|
|
Non-Reccuring Items |
0
|
|
Pre-Tax Income |
(15)
N/A
|
|
Net Income | ||
Tax Provision |
(2)
|
|
Income from Continuing Operations |
(17)
|
|
Net Income (Common) |
(17)
N/A
|
|
EPS (Diluted) |
-0.88
N/A
|